{"organizations": [], "uuid": "20a582833fcb66958847bc7ff34100a380052acb", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180228.html", "section_title": "Archive News &amp; Video for Wednesday, 28 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-valeant-announces-q4-earnings-per/brief-valeant-announces-q4-earnings-per-share-1-45-idUSASB0C7YT", "country": "US", "domain_rank": 408, "title": "BRIEF-Valeant Announces Q4 Earnings Per Share $1.45", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-28T20:10:00.000+02:00", "replies_count": 0, "uuid": "20a582833fcb66958847bc7ff34100a380052acb"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-valeant-announces-q4-earnings-per/brief-valeant-announces-q4-earnings-per-share-1-45-idUSASB0C7YT", "ord_in_thread": 0, "title": "BRIEF-Valeant Announces Q4 Earnings Per Share $1.45", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - valeant pharmaceuticals international inc", "sentiment": "neutral"}, {"name": "thomson reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 28 (Reuters) - Valeant Pharmaceuticals International Inc :\n* VALEANT ANNOUNCES FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS AND PROVIDES 2018 GUIDANCE\n* Q4 REVENUE FELL 10 PERCENT TO $2.163 BILLION * Q4 EARNINGS PER SHARE $1.45 * SEES FY 2018 REVENUE $8.1 BILLION TO $8.3 BILLION * Q4 EARNINGS PER SHARE VIEW $0.98, REVENUE VIEW $2.17 BILLION -- THOMSON REUTERS I/B/E/S\n* FY2018 REVENUE VIEW $8.34 BILLION -- THOMSON REUTERS I/B/E/S\n* VALEANT SEES 2018 FULL-YEAR ADJUSTED EBITDA IN RANGE OF $3.05 - $3.20 BILLION\n* VALEANT - ADJUSTED NET INCOME (NON-GAAP) Q4 WAS $347 MILLION\n* VALEANT - SINCE END OF Q1 2016, CO HAS REDUCED TOTAL DEBT BY MORE THAN 20 PERCENT\n* FY2018 EARNINGS PER SHARE VIEW $3.47, REVENUE VIEW $8.34 BILLION -- THOMSON REUTERS I/B/E/S\n* VALEANT - AS OF FEB. 28, REDUCED TOTAL DEBT BY OVER $6.7 BILLION SINCE END OF Q1 2016\n* VALEANT - IN 2017, CO RECORDED INCOME TAX BENEFIT OF $4.145 BILLION\n* VALEANT - SEES 2018 ADJUSTED EBITDA (NON-GAAP) IN RANGE OF $3.05 BILLION - $3.20 BILLION\n* VALEANT - AGREED TO RESOLVE SOLODYN ANTITRUST LITIGATIONS IN FEBRUARY 2018, WITH CLASS SETTLEMENT OF $58 MILLION BEING SUBJECT TO COURT APPROVAL\n* FY2018 REVENUE VIEW $8.34 BILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage: (Reuters.Brief@thomsonreuters.com)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-28T20:10:00.000+02:00", "crawled": "2018-03-01T21:11:53.013+02:00", "highlightTitle": ""}